failure to respond or late response
on 24 Aug 2023
Last Applicant/ Owned by
68723 Plankstadt
Serial Number
79323909 filed on 17th Sep 2021
Registration Number
N/A
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical, medical and veterinary preparations used as active excipient for Liquid Nanoparticle formulations in vaccines and other therapeutic delivery systems; dietetic food adapted for medical and veterinary use; food for babies; dietary supplements for human beings and animals; dietary supplements for controlling cholesterol; dietary and nutritional supplements for sports and increased perRead More
Pharmaceutical, medical and veterinary preparations used as active excipient for Liquid Nanoparticle formulations in vaccines and other therapeutic delivery systems; dietetic food adapted for medical and veterinary use; food for babies; dietary supplements for human beings and animals; dietary supplements for controlling cholesterol; dietary and nutritional supplements for sports and increased performance for medical purposes; nutritional additives, namely, antioxidants for medical purposes; cholesterol reducers; mineral nutritional supplements being nutritional food additives; nutritional additives in the nature of nutritional supplements for humans or animals primarily composed of vitamins, amino acids, minerals and trace elements for medical purposes; herbal teas for medical purposes
No 79323909
No Service/Collective Mark
No T66835
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
24th Aug 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
24th Aug 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
19th May 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
28th Apr 2023 | CHANGE OF OWNER RECEIVED FROM IB |
18th Apr 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
22nd Mar 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
22nd Mar 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
14th Mar 2023 | REFUSAL PROCESSED BY IB |
09th Feb 2023 | NON-FINAL ACTION WRITTEN |
09th Feb 2023 | NON-FINAL ACTION E-MAILED |